Premium
Defining the clinical phenotype of COVID‐19 in children
Author(s) -
Giacomet Vania,
Stracuzzi Marta,
Paradiso Laura,
Di Cosimo Maria Elisabetta,
Rubinacci Valeria,
Zuccotti GianVincenzo
Publication year - 2020
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.13355
Subject(s) - medicine , covid-19 , phenotype , betacoronavirus , coronavirus infections , medline , pandemic , virology , genetics , outbreak , infectious disease (medical specialty) , gene , disease , biology , political science , law
On January 7, 2020, a novel coronavirus (SARS‐CoV‐2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS‐CoV‐2 discovery, the corresponding disease (COVID‐19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID‐19 had been confirmed worldwide, with more than 318.599 deaths.